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Pulmonary alveolar microlithiasis (PAM) is a very rare autosomal recessive disorder in which
microliths are formed in the alveolar space. PAM is infrequently complicated by pulmonary
hypertension, the cause of which is unclear. The author in this paper found that the pulmonary
hypertension was caused by a marked decrease in pulmonary bascular beds. Here, an autopsy
case of PAM with a marked cor pulmonale is reported. A 14-year-old woman was found to have
an abnormal pulmonary shadow, but the cause was unclear. At 24 years, she was diagnosed
with a diffuse pulmonary abnormal shadow. At 42 years, she was diagnosed with PAM by
imaging techniques. Her condition gradually worsened and she had to be treated with oxygen.
She died of respiratory failure at 54 years. An autopsy revealed severe PAM and marked cor
pulmonale. The heart weighed 360 g and right ventricular thickness was 10 mm (normal, 2e
3 mm). Microscopically, the alveolar space was diffusely filled with microliths, and heart
failure cells were recognized. Bone formations were scattered. The alveolar walls showed
fibrous thickening, and pulmonary arteries showed atherosclerosis. The right ventricle showed
marked cardiac hypertrophy. Chronic severe liver congestion was noted. A morphometric anal-
ysis using CD34-stained specimens showed a marked decrease (one tenth) in pulmonary capil-
lary beds (capillary number: 8.6  3.1 per image), compared with normal lungs obtained from
two other autopsies (85.3  9.4 and 96.2  10,3). It was concluded that the cor pulmonale and
pulmonary hypertension in the present case were caused by the marked decrease of the
pulmonary arterial vascular beds. More research is required regarding the etiology and treat-
ment of PAM.
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Figure 1 Cut surface of the lung with pulmonary alveolar
microlithiasis. The lung had little air and was very hard.
Figure 3 The right ventricle shows marked dilation and
hypertrophy (cor pulmonale). The right ventricular myocar-
dium thickness is 10 mm (normal: 2e3 mm).
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Pulmonary alveolar microlithiasis (PAM) is a very rare
autosomal recessive disorder in which microliths are
formed in the alveolar space. A full review of the world
literature revealed 424 cases of PAM.1 Recently, the caus-
ative gene, SLC34A2, was identified.2,3 PAM is infrequently
complicated by pulmonary hypertension,4,5 the cause of
which is unclear. In this article, the author found that the
pulmonary hypertension was caused by a marked decrease
in pulmonary vascular beds. Here, an autopsy case of PAM
with marked cor pulmonale is reported.
Case report
A 14-year-old woman was diagnosed with an abnormal
pulmonary shadow, but the cause was unclear. At 24 years
old, she was found to have a diffuse pulmonary abnormal
shadow by routine chest XP. At 42 years, she was diagnosed
with PAM by imaging techniques, including CT. Her condition
gradually worsened and she had to be treated with oxygen.
She died of respiratory failure at 54 years, 40 years after the
first manifestations. Familiar history of PAM was absent.Figure 2 Touch smear of the lung shows numerous sandy
microliths.An autopsy revealed severe PAM and marked cor pul-
monale. The left lung weighed 780 g and the right was 980 g
(Fig. 1). On the cut surface, numerous microliths were
identified (Fig. 2), and both lungs showed a marked
decrease in air (Fig. 1). The heart weighed 360 g and
showed severe cor pulmonale; the right ventricle was
markedly dilated and right ventricular myocardial thickness
was 10 mm (normal: 2e3 mm) (Fig. 3).
Microscopically, the alveolar space was diffusely filled
with microliths, and destruction and dilations of alveolar
walls were recognized (Fig. 4). Heart failure cells were
recognized (Fig. 4). The alveolar walls showed fibrous
thickening (Fig. 4), and elastic fiber stain showed a
decrease in alveolar elastic fibers and pulmonary athero-
sclerosis (Fig. 5). The right ventricle showed marked
cardiac hypertrophy. Chronic severe liver congestion was
also noted. The cause of death was thought to be respira-
tory failure.
An immunohistochemical and morphometric analysis was
performed in the present case as well as two normal lung
autopsies. Immunohistochemical study for vasculatures wasFigure 4 The alveolar walls have numerous microliths. The
alveolar walls also show destruction and fibrous thickening. HE,
40.
Figure 6 CD-34 immunostaining in the present case (A) and
(A), while many capillaries are recognized in the normal lung
Figure 5 Elastic fiber stain shows pulmonary atheroscle-
rosis and decrease of elastic fiber and increase of collagen
fiber in the alveolar walls. Elastica van Gieson stain, 40.
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(B). A and B: Immunostaining, 100.performed using the Dako Envision method (Dako, Glostrup,
Denmark), as previously reported.6,7 The primary antibody
was anti-CD34 antibody (NU-4A1, Nichirei, Tokyo, Japan).
Fifty randomly selected high power fields were incorpo-
rated into 50 JPEG images, and the images were printed.
Then, the number of capillaries was counted. As a result,
the number of capillaries per image was 8.6  3.1 in the
present case (Fig. 6A) and 85.3  9.4 and 96.2  10.3 in the
two normal lungs (Fig. 6B).
Discussion
PAM is a very rare autosomal recessive disease. Autopsy
cases of PAM are extremely rare. Recently, the causative
gene of PAM (SLCA34A2) was identified.2,3 However, the
exact mechanism of formation of microliths is unclear. PAM
is infrequently complicated by portal hypertension and cor
pulmonale.1,4,5
A typical autopsy case of PAMwithmarked cor pulmonale is
presented here. The presence of marked cor pulmonale
strongly suggests the presence of pulmonary hypertension in
the present case. The cause of pulmonary hypertension and
cor pulmonale was speculative. The present case showed
destruction and fibrous thickening of alveolar walls. Inaddition, the author demonstrated by morphometry that the
pulmonary capillary beds decreased by about one tenth
compared to normal lungs. These findings strongly suggest
that decreased pulmonary capillary beds are responsible for
marked pulmonary hypertension and cor pulmonale.
The mechanism of the decrease in pulmonary capillaries
and fibrous thickening of alveolar walls is unclear in the
present case. It is speculated that chronic irritation of
microliths to alveolar walls caused pulmonary alveolar wall
fibrosis and destruction of alveolar wall capillaries.
The present case showed pulmonary arteriosclerosis in
addition to PAM, suggesting that pulmonary hypertension
was present. The presence of chronic liver congestion
suggests chronic right heart failure.
It was of interest that there were bone formations in the
microliths in the present case, suggesting that the micro-
lithiasis formation was long standing. Clinically, it was
suspected that PAM was present for 40 years.At present, no effective therapy for PAM exists and only
palliative therapy with oxygen is effective. Further studies
of treatment of PAM are required.
In summary, a typical autopsy case of PAMwithmarked cor
pulmonale is reported. The cor pulmonale and pulmonary
hypertension in the present case was likely caused by the
marked decrease of the pulmonary arterial vascular beds.
More research is required regarding the etiology and treat-
ment of PAM.
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